The drug, ritlecitinib, is a once-daily pill for kids ages 12 and older with severeThe medication will be sold under the brand name Litfulo, and is manufactured by Pfizer.According to Pfizer, a full year supply of Litfulo has a list price of $49,000, similar to other specialty dermatologic treatments. The company said the actual cost to patients will vary based on individual health care plans.
Maria Strattner, who is from Danbury, Connecticut, was 13 years old when she lost all her hair -- including her eyelashes and eyebrows -- within a span of two weeks and was diagnosed with severe alopecia areata. Maryann Strattner said her daughter found a clinical trial for ritlecitinib at Yale University in New Haven, Connecticut, and entered the trial in 2020.